A registered PHASE4 study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase 4
- Study design
- RANDOMIZED · PARALLEL · TREATMENT · NONE
- Evidence population
- Human clinical study registration
- Participants
- 900
- Population
- FEMALE · 18 Years to 40 Years
- Duration
- 2026-08-01 to 2026-08-01
- Intervention
- MetFORMIN; Matching Placebo; Theory-Based Behavioral Educational Program
- Comparator
- Matching Placebo Group
- Outcomes measured
- Change in Body Mass Index (BMI) From Baseline to 6 Months — Baseline to 6 months; Change in Serum Insulin From Baseline to 6 Months — Baseline to 6 months; Change in HOMA-IR From Baseline to 6 Months — Baseline to 6 months; Change in Total Cholesterol (TC) From Baseline to 6 Months — Baseline to 6 months; Change in Triglycerides (TG) From Baseline to 6 Months — Baseline to 6 months; Change in Low-Density Lipoprotein Cholesterol (LDL-C) From Baseline to 6 Months — Baseline to 6 months; Change in High-Density Lipoprotein Cholesterol (HDL-C) From Baseline to 6 Months — Baseline to 6 months; Change in Serum Vitamin B12 From Baseline to 6 Months — Baseline to 6 months; Change in Serum Iron From Baseline to 6 Months — Baseline to 6 months; Change in Serum Ferritin From Baseline to 6 Months — Baseline to 6 months; Change in Total Iron-Binding Capacity (TIBC) From Baseline to 6 Months — Baseline to 6 months; Change in Transferrin Saturation (TSAT) From Baseline to 6 Months — Baseline to 6 months; Change in Serum Erythropoietin (EPO) From Baseline to 6 Months — Baseline to 6 months; Change in Hemoglobin (Hb) From Baseline to 6 Months — Baseline to 6 months; Change in Hematocrit (Hct) From Baseline to 6 Months — Baseline to 6 months; Change in Mean Corpuscular Volume (MCV) From Baseline to 6 Months — Baseline to 6 months; Change in Mean Corpuscular Hemoglobin (MCH) From Baseline to 6 Months — Baseline to 6 months; Change in Mean Corpuscular Hemoglobin Concentration (MCHC) From Baseline to 6 Months — Baseline to 6 months; Change in Red Cell Distribution Width (RDW) From Baseline to 6 Months — Baseline to 6 months; Change in White Blood Cell (WBC) Count From Baseline to 6 Months — Baseline to 6 months
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Metformin · 100%Title contains controlled topic terminology. Summary contains controlled topic terminology. Source terminology contains a controlled topic term.
Automated source check 100% · update recency 100%. These figures help sort records; they are not medical ratings.